R33.0
Drug induced retention of urine
Clinical Classification Guidelines
Use Additional Code
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Medical Intelligence & Overview
Drug-induced retention of urine is a condition where the normal process of urination is disrupted due to certain medications. It results in the inability to fully empty the bladder, which can cause discomfort and other health issues. Recognized under the ICD-10 code R33.0, this condition emphasizes the importance of understanding medication side effects related to urinary retention. While many medications may cause this problem temporarily, persistent retention may require medical intervention to prevent complications.
Causes & Symptoms
Clinical Causes: Anticholinergic drugs used for allergies, colds, and depression Decongestants and antihistamines Certain antidepressants and antipsychotics Muscle relaxants Medications used for Parkinson’s disease, such as anticholinergics Some antihypertensive drugs, especially those affecting the nervous system Opioids and other pain medications Medications that affect the nervous system and bladder muscle control
Key Symptoms: Difficulty starting urination Weak or interrupted urine stream Feeling of incomplete bladder emptying Frequent urination or urgency Discomfort or pain in the lower abdomen or pelvic area Swelling of the bladder (known as bladder distension) In severe cases, urine leakage or retention of large amounts of urine
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a detailed medical history and physical examination, focusing on medication use and urinary symptoms. Healthcare providers may perform tests such as urine analysis, ultrasound of the bladder, and post-void residual volume measurements to assess bladder function and identify retention. It is essential to determine whether medication is contributing to the problem, which might involve reviewing current prescriptions or temporarily stopping certain drugs under medical supervision.
Treatment Protocols: Managing drug-induced retention of urine often involves several approaches. Discontinuing or adjusting the dose of the offending medication is usually the first step. In some cases, medications that relax the bladder or improve muscle function may be prescribed. Catheterization might be necessary temporarily to drain the bladder safely in severe cases. Addressing underlying health conditions and patient education on medication side effects are important aspects of treatment. In all cases, consultation with healthcare providers is essential to create a safe and effective treatment plan tailored to the individual's needs.
Clinical Advice & FAQs
Billing Guidance
Is R33.0 a billable ICD-10 code?
Yes, R33.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report R33.0?
Clinical documentation must specify the nature of Drug induced retention of urine and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
